NEWPORT NEWS, Va., Oct. 30, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) today reported results for the third quarter of fiscal 2025. HighlightsThird quarter revenues were a record $3.2 billion Third quarter net earnings were $145 million or $3.68 diluted earnings per share Completed builder’s sea trials for guided missile destroyer Ted Stevens (DDG 128) Completed initial sea trials of Virginia-Class Submarine Massachusetts (SSN 798) in early OctoberThird Quarter ResultsThird quarter 2025 revenues of $3.2 billion were up 16.1% from the third quarter of 2024, driven by growth at Newport News Shipbuilding, Ingalls Shipbuilding and Mission Technologies. Operating income in the third quarter of 2025 was $161 million and operating margin was 5.0%, compared to $82 million and 3.0%, respectively, in the third quarter of 2024. Segment...

Iceland Seafood will publish its Interim Financial Statement for Q3 2025 after closing of markets on November 13th 2025. This represents a change from the previously scheduled date of November 19th, moving the publication forward by six days. Iceland Seafood will pause hosting a meeting for investors and market participants for Q1 and Q3 until further notice. However, the company will host a meeting for investors and market participants for Q2 (half-year results) and Q4 (full-year results), where management will present and discuss the results.  Dates for those meetings can be found on the company website  www.icelandseafood.com/investors/shareholders/

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product sales Received 152 new patient start forms for EMPAVELI® (pegcetacoplan) in the first two months since launch in C3G and primary IC-MPGN Reported EMPAVELI U.S. net product revenue of $27 million, reflecting strong early launch in C3G and primary IC-MPGN and continued high patient compliance in PNH SYFOVRE® (pegcetacoplan injection) total injection demand grew 4% quarter-over-quarter, with U.S. net product revenue of $151 million Cash and cash equivalents of $479 million as of September 30, 2025; existing cash expected to be sufficient to fund business to sustainable profitability Management to host conference call today at 8:30 a.m. ETWALTHAM, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), today announced...

Quarterly revenue of $382 million – Softer than expected demand, particularly in our Truck Body business, led to revenue coming in below our guidance range. Parts & Services generated positive revenue growth sequentially and year-over-year. GAAP operating income of $58 million or Non-GAAP adjusted operating loss of $24 million; Excludes impact of $81 million gain related to the settlement of the Missouri legal verdict. Quarterly GAAP EPS of $0.97 or Non-GAAP adjusted EPS of $(0.51). Missing Expectations due to revenue miss and operational inefficiencies associated with lower than expected volumes. Total backlog of $829 million ending Q3; Market environment continues to be challenging as economic concerns and uncertainty remain. 2025 revenue outlook reduced to $1.5B, Non-GAAP adjusted EPS outlook reduced to $(2.00), excluding...

$12.9 million in third quarter PYRUKYND® (mitapivat) net revenues PDUFA goal date for PYRUKYND U.S. sNDA in thalassemia set for December 7, 2025 CHMP adopted positive opinion for PYRUKYND in thalassemia; EC decision expected by early 2026 RISE UP Phase 3 trial topline results in sickle cell disease by year-end; potential U.S. commercial launch in 2026 Phase 2b tebapivat trial in lower-risk MDS fully enrolled; topline results expected in early 2026 $1.3 billion dollars in cash, cash equivalents and marketable securities as of September 30, 2025CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced financial results and updates for the third quarter ended...

MARIETTA, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) — Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months of 2025. Significant Items for third quarter of 2025 (all comparisons to third quarter of 2024):Net premiums earned decreased 3.4% to $229.8 million Combined ratio of 95.9%, compared to 96.4% Net income of $20.1 million, or 55 cents per diluted Class A share, compared to $16.8 million, or 51 cents per diluted Class A share Net income included after-tax net investment gains of $1.0 million, or 3 cents per diluted Class A share, compared to $1.5 million, or 5 cents per diluted Class A share Annualized return on average equity of 13.0%, compared to 13.4% Book value per share of $17.14 at September 30, 2025, compared to $15.22Financial Summary                         Three...

– Achieves Record Leased-to-Economic Occupancy Spread –– New High in Small Shop Occupancy –– 4% Increase to Cash Dividend on Common Shares –– Raises 2025 Outlook Range – JERICHO, N.Y., Oct. 30, 2025 (GLOBE NEWSWIRE) — Kimco Realty® (NYSE: KIM), a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States, today reported results for the third quarter ended September 30, 2025. For the three months ended September 30, 2025 and 2024, Net income available to the company’s common shareholders (“Net income”) per diluted share was $0.19 for both periods. HighlightsProduced Funds From Operations(1) (“FFO”) of $0.44 per diluted share. Grew pro-rata portfolio occupancy to 95.7%, up 30 basis points sequentially. Reached an...

GREENWICH, Conn., Oct. 30, 2025 (GLOBE NEWSWIRE) — XPO (NYSE: XPO) today announced its financial results for the third quarter 2025. The company reported diluted earnings per share of $0.68, compared with $0.79 for the same period in 2024, and adjusted diluted earnings per share of $1.07, compared with $1.02 for the same period in 2024.Third Quarter 2025 Summary Results                                     Three Months Ended September 30,    Revenue   Operating Income (Loss)(1)(in millions)     2025     2024   Change %     2025       2024     Change %North American Less-Than-Truckload Segment   $ 1,255   $ 1,251   0.3 %   $ 208     $ 188     10.6 %European Transportation Segment     857     803   6.7 %     (2 )     6     NMCorporate     –     –   0.0 %     (42 )     (18 )   133.3 %Total   $ 2,111   $ 2,053   2.8 %   $ 164     $ 176     -6.8 %                                     Adjusted...

MONACO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE: STNG) (“Scorpio Tankers” or the “Company”) today reported its results for the three months ended September 30, 2025. The Company also announced that its board of directors (the “Board of Directors”) has declared a quarterly cash dividend on its common shares of $0.42 per share. Results for the three months ended September 30, 2025 and 2024 For the three months ended September 30, 2025, the Company had net income of $84.5 million, or $1.81 basic and $1.73 diluted earnings per share. For the three months ended September 30, 2025, the Company had adjusted net income (see Non-IFRS Measures section below) of $72.7 million, or $1.56 basic and $1.49 diluted earnings per share, which excludes from net income (i) a $12.7 million, or...

DALLAS, Oct. 30, 2025 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (NYSE: CSW or the “Company”) today reported record results for the fiscal 2026 second quarter period ended September 30, 2025. Fiscal 2026 Second Quarter Highlights (comparisons to fiscal 2025 second quarter)Total revenue increased 21.5% to a quarter record of $277.0 million, driven by acquisitions during the last twelve months Net income attributable to CSW of $40.7 million, increased 12.8% to a second quarter record, compared to $36.1 million Earnings per diluted share (“EPS”) of $2.41, increased 6.7% when compared to $2.26 Adjusted EPS of $2.96, excluding the amortization of acquisition-related intangible assets and transaction expenses, increased 15.2% when compared to $2.57 Adjusted EBITDA grew 19.9% to a quarter record of $72.9 million Paid...